1-6 of 6
Adele Capucci, MD
Close
Sort by
Journal Articles

REL-Protocol PhilosoPhi34: An Open Label, Single Arm, Phase II Study of Nilotinib 300 Mg BID in Newly Diagnosed Chronic Phase Chronic Myeloid Leukaemia Patients, to Study the Disappearance of CD34+/Lin-Ph+ Cells from Bone Marrow during Treatment. Preliminary Data

Ester Pungolino, MD, Giuseppe Rossi, MD, Maria Angela Mura, Alessandra Perego, MD, Ester Maria Orlandi, MD, Mauro Turrini, MD, Lorenza Borin, MD, Maria Adele Capucci, MD, Alessandra Iurlo, MD PhD, Alessandra Trojani, PhD, Mariella D'Adda, MD, Francesco Spina, MD, Gabriella De Canal, Maria Luisa Pioltelli, Maria Luisa Latargia, MD, Sergio Pauli, MD, Chiara Elena, MD, Stefania Brusorio, Francesco Lanza, MD, Simona Malato, MD, Michela Anghilieri, MD, Maria C Carraro, MD, Enrica Morra, MD, Roberto Cairoli, MD
Journal: Blood
Blood (2015) 126 (23): 1597.
https://doi.org/10.1182/blood.V126.23.1597.1597
Published: 2015
Journal Articles

A 3-Year Prospective Surveillance Study of Microbiological Isolates among Hematologic Inpatients Shows a High Frequency of Both Community-Acquired and Nosocomial Methicillin-Resistant (MR) and Fluoroquinolone-Resistant (FqR) Strains and the Recent Increase of Enterococci, Viridans Streptococci and Pseudomonaceae with Frequent Antibiotic Multiresistance.

Chiara Cattaneo, MD, Salvatore Casari, MD, Erika Borlenghi, MD, Maria Adele Capucci, MD, Moira Micheletti, MD, Alessandro Re, MD, Giampiero Carosi, MD, Giuseppe Rossi, MD
Journal: Blood
Blood (2007) 110 (11): 2286.
https://doi.org/10.1182/blood.V110.11.2286.2286
Published: 2007
Journal Articles

Treatment of Philadelphia Positive Chronic Myeloid Leukemia with Imatinib: Introducing the Concept of Confirmed Molecular Response.

Francesca Palandri, MD, Gianantonio Rosti, MD, Ilaria Iacobucci, MD, Nicoletta Testoni, MD, Fausto Castagnetti, MD, Massimo Breccia, MD, Elisabetta Abruzzese, MD, Bruno Martino, MD, Daniela Cilloni, MD, Fabrizio Pane, MD, Marco Gobbi, MD, Tamara Intermesoli, MD, Fabio Stagno, MD, Adele Capucci, MD, Giovanni Martinelli, MD, Michele Baccarani, MD
Journal: Blood
Blood (2007) 110 (11): 1933.
https://doi.org/10.1182/blood.V110.11.1933.1933
Published: 2007
Journal Articles

An Analysis of the Incidence, Risk Factors and Prognosis of Acute Promyelocytic Leukemia Following Mitoxantrone Therapy in Patients Affected by Multiple Sclerosis.

Chiara Cattaneo, MD, Erika Borlenghi, MD, Cinzia Cordioli, MD, Samantha Ferrari, MD, Antonio Regazzoli, MD, Giuseppina Ruggeri, MD, Elena Gobbi, Maria Adele Capucci, MD, Moira Micheletti, MD, Ruggero Capra, MD, Giuseppe Rossi, MD
Journal: Blood
Blood (2006) 108 (11): 4488.
https://doi.org/10.1182/blood.V108.11.4488.4488
Published: 2006
Journal Articles

Imatinib 400 mg in Early Chronic Phase CML: Results of a Multicentric, Prospective Non Academical Observational Study (by the GIMEMA CML Working Party).

Gianantonio Rosti, MD, Fausto Castagnetti, MD, Ilaria Iacobucci, BD, Marilina Amabile, BD, Francesca Palandri, MD, Panagiota Giannoulia, MD, Giuliana Alimena, MD, Nicoletta Testoni, BD, Simona Luatti, BD, Bruno Martino, MD, Giorgina Specchia, MD, Serena Rupoli, MD, Adele Capucci, MD, F. Cavazzini, MD, Franca Radaelli, MD, Ester Orlandi, MD, Giovanna Rege Cambrin, MD, Emilio Usala, MD, Nicoletta Testoni, MD, Fabrizio Pane, MD, Giuseppe Saglio, MD, Giovanni Martinelli, MD, Michele Baccarani, MD
Journal: Blood
Blood (2006) 108 (11): 4777.
https://doi.org/10.1182/blood.V108.11.4777.4777
Published: 2006
Journal Articles

Performance of IFIGC/MSG/EORTC Criteria for the Diagnosis of Invasive Pulmonary Aspergillosis in the Clinical Management of Unselected Patients with Acute Leukemia.

Erika Borlenghi, md, Maria Adele Capucci, md, Chiara Cattaneo, md, Nicoletta Petrella, md, Liana Signorini, md, Fabio Franco, md, Giuseppe Rossi, md
Journal: Blood
Blood (2004) 104 (11): 4519.
https://doi.org/10.1182/blood.V104.11.4519.4519
Published: 2004